<?xml version="1.0" encoding="UTF-8"?>
<fig id="Fig2">
 <label>Figure 2</label>
 <caption>
  <p>Dose-dependent anti-SARS-CoV-2 effects of six candidates at the post-infectious phase. (
   <bold>a</bold>) Study design. SARS-CoV-2 infected Vero E6 cells (at 25TCID
   <sub>50</sub>) were treated with the extract/compound for 48 h before harvest. (
   <bold>b</bold>) Controls. Hydroxychloroquine (HCQ) at the IC
   <sub>50</sub> (5.08 µM) for post-infection treatment (from Fig. 
   <xref rid="Fig1" ref-type="fig">1</xref>c) and the neutralizing serum served as the positive controls. (
   <bold>c</bold>–
   <bold>h</bold>) High-content imaging analysis of 
   <italic>Andrographis paniculata</italic> extract (
   <bold>c</bold>), 
   <italic>Zingiber officinale</italic> extract (
   <bold>d</bold>), 
   <italic>Boesenbergia rotunda</italic> extract (
   <bold>e</bold>), Andrographolide (
   <bold>f</bold>), 6-Gingerol (
   <bold>g</bold>), and panduratin A (
   <bold>h</bold>) was demonstrated in the left panel. The percentage of virus inhibition (blue) and cell viability (red) was shown in the right panel (n = 3 biological replicates). Fluorescent signals: green, anti-SARS-CoV-2 NP mAb; blue, Hoechst. (
   <bold>i</bold>–
   <bold>n</bold>) Plaque reduction assay of six candidates, i.e., 
   <italic>A. paniculata</italic> extract (
   <bold>i</bold>), 
   <italic>Z. officinale</italic> extract (
   <bold>j</bold>), 
   <italic>B. rotunda</italic> extract (
   <bold>k</bold>), Andrographolide (
   <bold>l</bold>), 6-Gingerol (
   <bold>m</bold>), and panduratin A (
   <bold>n</bold>) (n = 2 biological replicates).
  </p>
 </caption>
 <graphic xlink:href="41598_2020_77003_Fig2_HTML" id="MO2" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
